Display options
Cite
Salas-Treviño D, Saucedo-Cárdenas O, Loera-Arias MJ, et al. Hyaluronate Functionalized Multi-Wall Carbon Nanotubes Filled with Carboplatin as a Novel Drug Nanocarrier against Murine Lung Cancer Cells. Nanomaterials (Basel). 2019;9(11)doi: 10.3390/nano9111572.
Salas-Treviño, D., Saucedo-Cárdenas, O., Loera-Arias, M. J., Rodríguez-Rocha, H., García-García, A., Montes-de-Oca-Luna, R., Piña-Mendoza, E. I., Contreras-Torres, F. F., García-Rivas, G., & Soto-Domínguez, A. (2019). Hyaluronate Functionalized Multi-Wall Carbon Nanotubes Filled with Carboplatin as a Novel Drug Nanocarrier against Murine Lung Cancer Cells. Nanomaterials (Basel, Switzerland), 9(11), . https://doi.org/10.3390/nano9111572
Salas-Treviño, Daniel, et al. "Hyaluronate Functionalized Multi-Wall Carbon Nanotubes Filled with Carboplatin as a Novel Drug Nanocarrier against Murine Lung Cancer Cells." Nanomaterials (Basel, Switzerland) vol. 9,11 (2019). doi: https://doi.org/10.3390/nano9111572
Salas-Treviño D, Saucedo-Cárdenas O, Loera-Arias MJ, Rodríguez-Rocha H, García-García A, Montes-de-Oca-Luna R, Piña-Mendoza EI, Contreras-Torres FF, García-Rivas G, Soto-Domínguez A. Hyaluronate Functionalized Multi-Wall Carbon Nanotubes Filled with Carboplatin as a Novel Drug Nanocarrier against Murine Lung Cancer Cells. Nanomaterials (Basel). 2019 Nov 06;9(11). doi: 10.3390/nano9111572. PMID: 31698759; PMCID: PMC6915394.
Copy Download .nbib Format: NLM
Share it on

Nanomaterials (Basel). 2019 Nov 06;9(11). doi: 10.3390/nano9111572.

Hyaluronate Functionalized Multi-Wall Carbon Nanotubes Filled with Carboplatin as a Novel Drug Nanocarrier against Murine Lung Cancer Cells.

Nanomaterials (Basel, Switzerland)

Daniel Salas-Treviño, Odila Saucedo-Cárdenas, María de Jesús Loera-Arias, Humberto Rodríguez-Rocha, Aracely García-García, Roberto Montes-de-Oca-Luna, Edgar I Piña-Mendoza, Flavio F Contreras-Torres, Gerardo García-Rivas, Adolfo Soto-Domínguez

Affiliations

  1. Departamento de Histología, Facultad de Medicina, Universidad Autónoma de Nuevo León, Monterrey C.P. 64460, Mexico.
  2. Departamento de Genética Molecular, Centro de Investigación Biomédica del Noreste (CIBIN) del IMSS, Monterrey C.P. 64720, Mexico.
  3. Escuela de Ingeniería y Ciencias, Tecnológico de Monterrey, Monterrey C.P. 64849, Mexico.
  4. Escuela de Medicina, Tecnológico de Monterrey, Monterrey 64849, Mexico.

PMID: 31698759 PMCID: PMC6915394 DOI: 10.3390/nano9111572

Abstract

Carbon nanotubes (CNTs) have emerged in recent years as a potential option for drug delivery, due to their high functionalization capacity. Biocompatibility and selectivity using tissue-specific biomolecules can optimize the specificity, pharmacokinetics and stability of the drug. In this study, we design, develop and characterize a drug nanovector (oxCNTs-HA-CPT) conjugating oxidated multi-wall carbon nanotubes (oxCNTs) with hyaluronate (HA) and carboplatin (CPT) as a treatment in a lung cancer model in vitro. Subsequently, we exposed TC-1 and NIH/3T3 cell lines to the nanovectors and measured cell uptake, cell viability, and oxidative stress induction. The characterization of oxCNTs-HA-CPT reveals that on their surface, they have HA. On the other hand, oxCNTs-HA-CPT were endocytosed in greater proportion by tumor cells than by fibroblasts, and likewise, the cytotoxic effect was significantly higher in tumor cells. These results show the therapeutic potential that nanovectors possess; however, future studies should be carried out to determine the death pathways involved, as well as their effect on in vivo models.

Keywords: carboplatin; hyaluronate; multi-wall carbon nanotubes; nanomedicine; tumor cells

References

  1. Biomaterials. 2014 Jan;35(2):748-59 - PubMed
  2. Biomed Res Int. 2015;2015:793186 - PubMed
  3. Expert Opin Drug Deliv. 2015 Apr;12(4):563-81 - PubMed
  4. Biochem Biophys Res Commun. 2013 Oct 18;440(2):348-53 - PubMed
  5. Mater Sci Eng C Mater Biol Appl. 2016 Nov 1;68:579-584 - PubMed
  6. Int J Biol Macromol. 2019 Feb 15;123:691-703 - PubMed
  7. Nanomedicine (Lond). 2009 Oct;4(7):763-72 - PubMed
  8. ACS Nano. 2010 Dec 28;4(12):7241-52 - PubMed
  9. Proc Natl Acad Sci U S A. 1994 Jul 5;91(14):6609-13 - PubMed
  10. J Colloid Interface Sci. 2012 Jan 1;365(1):143-9 - PubMed
  11. Nanomedicine. 2016 Feb;12(2):333-51 - PubMed
  12. Nanoscale. 2015 Mar 12;7(12):5383-94 - PubMed
  13. Carbohydr Res. 2015 Mar 20;405:70-7 - PubMed
  14. J Thorac Oncol. 2014 May;9(5):702-9 - PubMed
  15. Apoptosis. 2008 Jul;13(7):883-94 - PubMed
  16. Mol Cell Biochem. 2011 Jun;352(1-2):57-63 - PubMed
  17. Biosensors (Basel). 2017 Feb 15;7(1): - PubMed
  18. J Nanosci Nanotechnol. 2015 Mar;15(3):2105-14 - PubMed
  19. Rom J Morphol Embryol. 2015;56(2):349-56 - PubMed
  20. Toxicol In Vitro. 2016 Dec;37:189-200 - PubMed
  21. Carbon N Y. 2019 May 2;50(4):1625-1634 - PubMed
  22. Int J Mol Sci. 2014 Dec 23;16(1):40-8 - PubMed
  23. J Hazard Mater. 2016 Apr 5;306:193-202 - PubMed
  24. Food Chem Toxicol. 2011 Oct;49(10):2670-5 - PubMed
  25. Int J Nanomedicine. 2012;7:5361-74 - PubMed
  26. Mol Neurobiol. 2019 Dec;56(12):8136-8156 - PubMed
  27. Bioconjug Chem. 2012 Nov 21;23(11):2201-13 - PubMed
  28. Nanomedicine. 2014 Oct;10(7):1465-75 - PubMed
  29. ACS Nano. 2016 Aug 23;10(8):7675-88 - PubMed
  30. J Am Chem Soc. 2008 Aug 27;130(34):11467-76 - PubMed
  31. Nanotechnology. 2010 Aug 20;21(33):335101 - PubMed
  32. Nanomedicine (Lond). 2008 Apr;3(2):175-82 - PubMed
  33. Int J Pharm. 2016 Mar 30;501(1-2):278-99 - PubMed
  34. Expert Opin Drug Discov. 2012 Nov;7(11):1029-37 - PubMed
  35. Histol Histopathol. 1997 Apr;12(2):525-35 - PubMed
  36. Free Radic Biol Med. 2006 Apr 1;40(7):1227-33 - PubMed
  37. Nanoscale. 2010 Mar;2(3):373-80 - PubMed
  38. Pharm Res. 2013 Feb;30(2):412-23 - PubMed

Publication Types